Meeting
2017 ASCO Annual Meeting
Role of adjuvant chemoradiation in treatment of elderly women with advanced high-grade endometrial cancer: A SEER-Medicare analysis.
Authors
Hyo K. Park
Karmanos Cancer Institute, Detroit, MI
Hyo K. Park , Julie J. Ruterbusch , Michele L. Cote
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Uterine Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 5589)
DOI
10.1200/JCO.2017.35.15_suppl.5589
Abstract #
5589
Poster Bd #
411
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Differences in survival outcomes in advanced endometrial cancer due to variation in adjuvant therapy and histology.
First Author: Emily Meichun Ko
Poster
2021 ASCO Annual Meeting
Treatment patterns and outcomes among patients with microsatellite stable (MSS) advanced endometrial cancer in the United States: Endometrial Cancer Health Outcomes (ECHO) retrospective chart review Study.
First Author: Shelby Corman
Poster
2023 ASCO Annual Meeting
Overall survival and subsequent therapy from a phase II study of sintilimab and anlotinib in patients with advanced or recurrent endometrial cancer.
First Author: Zhen Zeng
Poster
2023 ASCO Annual Meeting
Randomized phase III trial in MMR deficient (MMRd) endometrial cancer (EC) patients comparing chemotherapy (CT) alone versus dostarlimab in first line advanced/metastatic setting: DOMENICA study (GINECO-EN105b/ENGOT-en13 study).
First Author: Florence Joly